nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—cranial nerve—meningioma	0.112	0.167	CbGeAlD
Loperamide—POMC—telencephalic ventricle—meningioma	0.0909	0.136	CbGeAlD
Loperamide—CALM1—trigeminal nerve—meningioma	0.0426	0.0639	CbGeAlD
Loperamide—OPRM1—telencephalic ventricle—meningioma	0.0342	0.0512	CbGeAlD
Loperamide—CALM1—cranial nerve—meningioma	0.0304	0.0455	CbGeAlD
Loperamide—CALM2—pons—meningioma	0.0302	0.0452	CbGeAlD
Loperamide—CALM1—pons—meningioma	0.03	0.045	CbGeAlD
Loperamide—POMC—brainstem—meningioma	0.0246	0.0368	CbGeAlD
Loperamide—CACNA1A—brainstem—meningioma	0.0235	0.0352	CbGeAlD
Loperamide—CALM2—pineal body—meningioma	0.0215	0.0322	CbGeAlD
Loperamide—CALM1—pineal body—meningioma	0.0214	0.0321	CbGeAlD
Loperamide—POMC—medulla oblongata—meningioma	0.0171	0.0257	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—meningioma	0.0164	0.0245	CbGeAlD
Loperamide—POMC—spinal cord—meningioma	0.0153	0.0229	CbGeAlD
Loperamide—POMC—cerebellum—meningioma	0.0121	0.0182	CbGeAlD
Loperamide—CACNA1A—cerebellum—meningioma	0.0116	0.0173	CbGeAlD
Loperamide—POMC—brain—meningioma	0.00985	0.0147	CbGeAlD
Loperamide—CACNA1A—brain—meningioma	0.0094	0.0141	CbGeAlD
Loperamide—OPRM1—brainstem—meningioma	0.00925	0.0139	CbGeAlD
Loperamide—CALM2—brainstem—meningioma	0.00672	0.0101	CbGeAlD
Loperamide—CALM1—brainstem—meningioma	0.00668	0.01	CbGeAlD
Loperamide—OPRK1—cerebellum—meningioma	0.00641	0.00961	CbGeAlD
Loperamide—CALM3—medulla oblongata—meningioma	0.00596	0.00893	CbGeAlD
Loperamide—OPRM1—spinal cord—meningioma	0.00575	0.00862	CbGeAlD
Loperamide—OPRD1—brain—meningioma	0.00543	0.00814	CbGeAlD
Loperamide—CALM3—spinal cord—meningioma	0.00532	0.00796	CbGeAlD
Loperamide—OPRK1—brain—meningioma	0.00521	0.0078	CbGeAlD
Loperamide—CALM2—medulla oblongata—meningioma	0.00468	0.00701	CbGeAlD
Loperamide—CALM1—medulla oblongata—meningioma	0.00466	0.00698	CbGeAlD
Loperamide—CALM3—cerebellum—meningioma	0.00422	0.00631	CbGeAlD
Loperamide—CALM2—spinal cord—meningioma	0.00418	0.00625	CbGeAlD
Loperamide—CALM1—spinal cord—meningioma	0.00416	0.00623	CbGeAlD
Loperamide—CYP2D6—brainstem—meningioma	0.00371	0.00556	CbGeAlD
Loperamide—OPRM1—brain—meningioma	0.00371	0.00555	CbGeAlD
Loperamide—CALM3—brain—meningioma	0.00342	0.00513	CbGeAlD
Loperamide—CALM2—cerebellum—meningioma	0.00331	0.00496	CbGeAlD
Loperamide—CALM1—cerebellum—meningioma	0.0033	0.00494	CbGeAlD
Loperamide—CALM2—brain—meningioma	0.00269	0.00403	CbGeAlD
Loperamide—CALM1—brain—meningioma	0.00268	0.00401	CbGeAlD
Loperamide—CYP2C8—brain—meningioma	0.00223	0.00334	CbGeAlD
Loperamide—CYP2B6—brain—meningioma	0.002	0.00299	CbGeAlD
Loperamide—ABCB1—medulla oblongata—meningioma	0.00186	0.00279	CbGeAlD
Loperamide—CYP2D6—cerebellum—meningioma	0.00183	0.00274	CbGeAlD
Loperamide—ABCB1—spinal cord—meningioma	0.00166	0.00249	CbGeAlD
Loperamide—CYP2D6—brain—meningioma	0.00149	0.00223	CbGeAlD
Loperamide—ABCB1—cerebellum—meningioma	0.00132	0.00197	CbGeAlD
Loperamide—ABCB1—brain—meningioma	0.00107	0.0016	CbGeAlD
Loperamide—CALM2—Signaling by GPCR—TSHB—meningioma	0.000316	0.000952	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TSHB—meningioma	0.000316	0.000952	CbGpPWpGaD
Loperamide—CALM3—ErbB1 downstream signaling—AKT1—meningioma	0.000315	0.000947	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SMO—meningioma	0.000314	0.000944	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TSHB—meningioma	0.000312	0.000939	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALAD—meningioma	0.000312	0.000938	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD34—meningioma	0.000311	0.000935	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD34—meningioma	0.000311	0.000935	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—AKT1—meningioma	0.00031	0.000934	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00031	0.000933	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000308	0.000927	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000308	0.000927	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTSL—meningioma	0.000307	0.000922	CbGpPWpGaD
Loperamide—CALM1—ErbB1 downstream signaling—AKT1—meningioma	0.000304	0.000916	CbGpPWpGaD
Loperamide—CALM2—ErbB1 downstream signaling—AKT1—meningioma	0.000304	0.000916	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PGR—meningioma	0.000301	0.000906	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000301	0.000905	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.0003	0.000902	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.0003	0.000902	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—PTEN—meningioma	0.000299	0.000899	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTSL—meningioma	0.000296	0.000892	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTSL—meningioma	0.000296	0.000892	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—AKT1—meningioma	0.000293	0.000881	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—PTEN—meningioma	0.000289	0.00087	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—ERBB2—meningioma	0.000287	0.000864	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—AKT1—meningioma	0.000283	0.000852	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—AKT1—meningioma	0.000283	0.000852	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—AKT1—meningioma	0.000282	0.000848	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—SMO—meningioma	0.000278	0.000836	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—ERBB2—meningioma	0.000278	0.000836	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—ERBB2—meningioma	0.000278	0.000836	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALAD—meningioma	0.000272	0.000817	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—PDGFB—meningioma	0.000272	0.000817	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—SMO—meningioma	0.000269	0.000809	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—SMO—meningioma	0.000269	0.000809	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SMO—meningioma	0.000265	0.000798	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—PLAU—meningioma	0.000263	0.000793	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—PDGFB—meningioma	0.000263	0.00079	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—PDGFB—meningioma	0.000263	0.00079	CbGpPWpGaD
Loperamide—CALM3—Disease—CST3—meningioma	0.000261	0.000786	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000256	0.000772	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALAD—meningioma	0.000256	0.00077	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—PLAU—meningioma	0.000255	0.000767	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—PLAU—meningioma	0.000255	0.000767	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PGR—meningioma	0.000254	0.000765	CbGpPWpGaD
Loperamide—CALM2—Disease—CST3—meningioma	0.000253	0.00076	CbGpPWpGaD
Loperamide—CALM1—Disease—CST3—meningioma	0.000253	0.00076	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—PTEN—meningioma	0.000245	0.000737	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—PDGFB—meningioma	0.000244	0.000736	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—AKT1—meningioma	0.000238	0.000716	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—TSHB—meningioma	0.000237	0.000714	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—PTEN—meningioma	0.000237	0.000713	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—PTEN—meningioma	0.000237	0.000713	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—PDGFB—meningioma	0.000236	0.000712	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—PDGFB—meningioma	0.000236	0.000712	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—PDGFB—meningioma	0.000235	0.000706	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HES1—meningioma	0.000235	0.000706	CbGpPWpGaD
Loperamide—CALM3—Metabolism—TSHB—meningioma	0.000231	0.000695	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—AKT1—meningioma	0.00023	0.000692	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—AKT1—meningioma	0.00023	0.000692	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—PDGFB—meningioma	0.000227	0.000683	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—PDGFB—meningioma	0.000227	0.000683	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—AKT1—meningioma	0.000224	0.000673	CbGpPWpGaD
Loperamide—CALM2—Metabolism—TSHB—meningioma	0.000223	0.000672	CbGpPWpGaD
Loperamide—CALM1—Metabolism—TSHB—meningioma	0.000223	0.000672	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—AKT1—meningioma	0.000222	0.000669	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—AKT1—meningioma	0.000221	0.000666	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—AKT1—meningioma	0.00022	0.000663	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—AKT1—meningioma	0.000216	0.000651	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—AKT1—meningioma	0.000216	0.000651	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—AKT1—meningioma	0.000215	0.000648	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—AKT1—meningioma	0.000215	0.000648	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—AKT1—meningioma	0.000214	0.000644	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—AKT1—meningioma	0.000214	0.000644	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—AKT1—meningioma	0.000213	0.000641	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—AKT1—meningioma	0.000213	0.000641	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—AKT1—meningioma	0.000207	0.000624	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000207	0.000624	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—AKT1—meningioma	0.000207	0.000624	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HES1—meningioma	0.000206	0.000619	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—AKT1—meningioma	0.000205	0.000618	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—AKT1—meningioma	0.000204	0.000613	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—AKT1—meningioma	0.000203	0.00061	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TSHB—meningioma	0.000201	0.000605	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PDGFB—meningioma	0.000201	0.000604	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—AKT1—meningioma	0.0002	0.000603	CbGpPWpGaD
Loperamide—POMC—Metabolism—AKT1—meningioma	0.000199	0.000599	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—AKT1—meningioma	0.000199	0.000598	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—AKT1—meningioma	0.000199	0.000598	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—meningioma	0.000197	0.000594	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—AKT1—meningioma	0.000197	0.000593	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000197	0.000593	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—AKT1—meningioma	0.000196	0.00059	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—AKT1—meningioma	0.000196	0.00059	CbGpPWpGaD
Loperamide—CALM3—Membrane Trafficking—AKT1—meningioma	0.000196	0.000589	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TSHB—meningioma	0.000193	0.000581	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—AKT1—meningioma	0.000192	0.000577	CbGpPWpGaD
Loperamide—CALM1—Membrane Trafficking—AKT1—meningioma	0.000189	0.00057	CbGpPWpGaD
Loperamide—CALM2—Membrane Trafficking—AKT1—meningioma	0.000189	0.00057	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TSHB—meningioma	0.000187	0.000562	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TSHB—meningioma	0.000187	0.000562	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—AKT1—meningioma	0.000186	0.000558	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—AKT1—meningioma	0.000186	0.000558	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000184	0.000552	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000178	0.000534	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000178	0.000534	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PDGFB—meningioma	0.000176	0.000529	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TSHB—meningioma	0.000175	0.000527	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000175	0.000527	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HES1—meningioma	0.000174	0.000523	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000174	0.000522	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—AKT1—meningioma	0.000172	0.000518	CbGpPWpGaD
Loperamide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.00017	0.000511	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000168	0.000505	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000168	0.000505	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALAD—meningioma	0.000167	0.000504	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—AKT1—meningioma	0.000167	0.000501	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TSHB—meningioma	0.000165	0.000496	CbGpPWpGaD
Loperamide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000164	0.000494	CbGpPWpGaD
Loperamide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.000164	0.000494	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SMO—meningioma	0.000164	0.000494	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—ERBB2—meningioma	0.000164	0.000493	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SMO—meningioma	0.000159	0.000478	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SMO—meningioma	0.000159	0.000478	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—ERBB2—meningioma	0.000158	0.000477	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—ERBB2—meningioma	0.000158	0.000477	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—AKT1—meningioma	0.000158	0.000475	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PGR—meningioma	0.000157	0.000474	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ERBB2—meningioma	0.000157	0.000473	CbGpPWpGaD
Loperamide—CALM3—Disease—HES1—meningioma	0.000154	0.000463	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—AKT1—meningioma	0.000153	0.000459	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—AKT1—meningioma	0.000153	0.000459	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PGR—meningioma	0.000152	0.000458	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PGR—meningioma	0.000152	0.000458	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ERBB2—meningioma	0.000152	0.000458	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ERBB2—meningioma	0.000152	0.000458	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PDGFB—meningioma	0.000149	0.000447	CbGpPWpGaD
Loperamide—CALM2—Disease—HES1—meningioma	0.000149	0.000447	CbGpPWpGaD
Loperamide—CALM1—Disease—HES1—meningioma	0.000149	0.000447	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000148	0.000445	CbGpPWpGaD
Loperamide—CALM3—Immune System—PDGFB—meningioma	0.000142	0.000428	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—AKT1—meningioma	0.000141	0.000425	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—PTEN—meningioma	0.00014	0.00042	CbGpPWpGaD
Loperamide—CALM2—Immune System—PDGFB—meningioma	0.000138	0.000414	CbGpPWpGaD
Loperamide—CALM1—Immune System—PDGFB—meningioma	0.000138	0.000414	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—AKT1—meningioma	0.000137	0.000411	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—AKT1—meningioma	0.000137	0.000411	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—PTEN—meningioma	0.000135	0.000407	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—PTEN—meningioma	0.000135	0.000407	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ERBB2—meningioma	0.000134	0.000405	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—PTEN—meningioma	0.000134	0.000404	CbGpPWpGaD
Loperamide—CALM3—Disease—PDGFB—meningioma	0.000131	0.000396	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—AKT1—meningioma	0.00013	0.000391	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—PTEN—meningioma	0.00013	0.000391	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—PTEN—meningioma	0.00013	0.000391	CbGpPWpGaD
Loperamide—CALM2—Disease—PDGFB—meningioma	0.000127	0.000383	CbGpPWpGaD
Loperamide—CALM1—Disease—PDGFB—meningioma	0.000127	0.000383	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—AKT1—meningioma	0.000126	0.000378	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—AKT1—meningioma	0.000126	0.000378	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AKT1—meningioma	0.000123	0.000371	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000123	0.00037	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ERBB2—meningioma	0.000118	0.000355	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PTEN—meningioma	0.000115	0.000345	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—meningioma	0.000112	0.000337	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—meningioma	0.000108	0.000325	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TSHB—meningioma	0.000108	0.000325	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HES1—meningioma	0.000108	0.000324	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—meningioma	0.000106	0.000319	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HES1—meningioma	0.000104	0.000313	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HES1—meningioma	0.000104	0.000313	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—meningioma	0.000102	0.000308	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—meningioma	0.000102	0.000308	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PTEN—meningioma	0.000101	0.000303	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ERBB2—meningioma	9.97e-05	0.0003	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—meningioma	9.81e-05	0.000295	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB2—meningioma	9.54e-05	0.000287	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB2—meningioma	9.23e-05	0.000278	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB2—meningioma	9.23e-05	0.000278	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PDGFB—meningioma	9.21e-05	0.000277	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—meningioma	9.13e-05	0.000275	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—meningioma	8.94e-05	0.000269	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PDGFB—meningioma	8.9e-05	0.000268	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PDGFB—meningioma	8.9e-05	0.000268	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB2—meningioma	8.81e-05	0.000265	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—meningioma	8.65e-05	0.00026	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—meningioma	8.65e-05	0.00026	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB2—meningioma	8.52e-05	0.000256	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB2—meningioma	8.52e-05	0.000256	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PTEN—meningioma	8.5e-05	0.000256	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—meningioma	8.29e-05	0.00025	CbGpPWpGaD
Loperamide—CALM3—Immune System—PTEN—meningioma	8.14e-05	0.000245	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—meningioma	8.05e-05	0.000242	CbGpPWpGaD
Loperamide—CALM1—Immune System—PTEN—meningioma	7.87e-05	0.000237	CbGpPWpGaD
Loperamide—CALM2—Immune System—PTEN—meningioma	7.87e-05	0.000237	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—meningioma	7.83e-05	0.000236	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—meningioma	7.79e-05	0.000234	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—meningioma	7.79e-05	0.000234	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—meningioma	7.73e-05	0.000233	CbGpPWpGaD
Loperamide—CALM3—Disease—PTEN—meningioma	7.51e-05	0.000226	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—meningioma	7.48e-05	0.000225	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—meningioma	7.48e-05	0.000225	CbGpPWpGaD
Loperamide—CALM1—Disease—PTEN—meningioma	7.27e-05	0.000219	CbGpPWpGaD
Loperamide—CALM2—Disease—PTEN—meningioma	7.27e-05	0.000219	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—meningioma	6.86e-05	0.000207	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—meningioma	6.61e-05	0.000199	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTEN—meningioma	6.47e-05	0.000195	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTEN—meningioma	6.29e-05	0.000189	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB2—meningioma	6.17e-05	0.000186	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTEN—meningioma	6.09e-05	0.000183	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTEN—meningioma	6.09e-05	0.000183	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB2—meningioma	5.97e-05	0.00018	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB2—meningioma	5.97e-05	0.00018	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—meningioma	5.8e-05	0.000175	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—meningioma	5.8e-05	0.000174	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTEN—meningioma	5.47e-05	0.000165	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTEN—meningioma	5.26e-05	0.000158	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—meningioma	5.13e-05	0.000154	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTEN—meningioma	5.09e-05	0.000153	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTEN—meningioma	5.09e-05	0.000153	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—meningioma	4.97e-05	0.000149	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—meningioma	4.97e-05	0.000149	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—meningioma	4.9e-05	0.000147	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTEN—meningioma	4.77e-05	0.000143	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—meningioma	4.69e-05	0.000141	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—meningioma	4.54e-05	0.000137	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—meningioma	4.54e-05	0.000137	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTEN—meningioma	4.49e-05	0.000135	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—meningioma	4.33e-05	0.00013	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—meningioma	4.19e-05	0.000126	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—meningioma	4.19e-05	0.000126	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—meningioma	3.73e-05	0.000112	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—meningioma	3.63e-05	0.000109	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—meningioma	3.59e-05	0.000108	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—meningioma	3.51e-05	0.000106	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—meningioma	3.51e-05	0.000106	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—meningioma	3.47e-05	0.000105	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—meningioma	3.47e-05	0.000105	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—meningioma	3.15e-05	9.49e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—meningioma	3.03e-05	9.12e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTEN—meningioma	2.94e-05	8.84e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—meningioma	2.93e-05	8.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—meningioma	2.93e-05	8.83e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—meningioma	2.75e-05	8.27e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—meningioma	2.59e-05	7.79e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—meningioma	1.69e-05	5.09e-05	CbGpPWpGaD
